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Abstract
Background: The relationship of maternal glomerular filtration rate (GFR) in pregnancy to fetal size needs to be better
characterized as it impacts an ongoing debate about confounding effect of maternal GFR in investigations of important
environmental contaminants. We aimed to characterize the size of the association between maternal GFR and infant birth
weight.
Materials and Methods: A sub-cohort of 953 selected women (470 women with and 483 women without preeclampsia) in
the Norwegian Mother and Child Cohort (MoBa), recruited during 2003–2007 were analyzed. GFR in the second trimester
was estimated based on plasma creatinine. Birth weight was ascertained from the Medical Birth Registry of Norway.
Multivariate linear regression was used to evaluate the association between maternal GFR in second trimester (estimated by
the Cockroft-Gault [GFR-CG] and the modification of diet in renal disease [GFR-MDRD] formulas) and infant birth weight.
Partial correlation coefficients were also calculated.
Results: Maternal GFR-CG (b: 0.73 g/ml/min, p = 0.04) and GFR-MDRD (b: 0.83 g/ml/min, p = 0.04) were associated with
infant birth weight in models adjusted for maternal weight in kilograms, preeclampsia, and gestational age at delivery
(days). Partial correlation coefficients for the association between infant birth weight and GFR were 0.07 for both formulas.
Although the birth weight-GFR association was stronger among the women with preeclampsia, the difference from women
without preeclampsia was not statistically significant.
Conclusion: These data support an association between GFR during pregnancy and infant birth weight, and indicate that
GFR may confound selected epidemiologic associations.
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Introduction
The relationship of glomerular filtration rate (GFR) in
pregnancy to fetal size needs to be better characterized because
the size of the association impacts an important ongoing debate in
environmental health. Perfluoroalkyl substances (PFAS) are
environmental contaminants detectable in the serum of nearly
everyone [1], and the relation of exposure to health outcomes is
under active investigation [2,3]. That birth weight is negatively
associated with serum concentration of PFAS has been shown with
remarkable consistency [4–7]. Because PFAS are excreted in
proportion to GFR, if, as indicated in several studies, GFR is
proportional to fetal size, the PFAS-birth weight association could
be due to confounding by GFR rather than a toxic effect of PFAS
[8]. The extent to which the PFAS-birth weight association is
confounded by GFR depends on the strength of the GFR-fetal size
relationship, but almost nothing is known about it.
Direct measures of GFR in pregnancy and birth weight were
made in two small studies [9,10]; these can be used to estimate the
size of the GFR-birth weight relation, and give widely differing
values (see below). Indirect measures of GFR in pregnancy, such as
serum creatinine and uric acid, also support a positive relationship
with birth weight [11–13]. Of the existing studies relevant to the
GFR-fetal size relationship, none have quantitated it in straight-
forward physiologic terms such as grams per fetal weight per ml/
min GFR.
In line with previous findings in the field, we hypothesized that
there is an association between maternal estimated GFR (eGFR)
in mid-pregnancy and fetal birth weight. The specific aim of this
study was to characterize the association between maternal eGFR
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and fetal size at birth in a large sample of pregnant women from
Norway. GFR can be measured either directly by clearance of
inulin or iohexol, or estimated indirectly by using the patient’s
plasma creatinine value. In this study GFR was estimated using
three widely used indirect methods; the Cockroft and Gault (CG),
the Modification of Diet in Renal Disease (MDRD), and the




The analyzed data were obtained from a sub-study within the
Norwegian Mother and Child Cohort Study (MoBa) conducted by
the Norwegian Institute of Public Health [17,18]. The majority of
pregnant women giving birth in Norway during the 1999–2008
were invited to participate in MoBa at their routine ultrasound
scan in gestational week 17–18 and 38.5% of invited women
consented to participate. The cohort includes 108 000 children, 90
700 mothers, and 71 500 fathers. Blood samples were obtained
from both parents at inclusion (in week 17–18) and from mothers
and children (umbilical cord) at birth [19]. The fourth version of
the quality-assured data files provided all data that were used for
the present study.
The subjects in the current study were originally selected for a
case-cohort study on PFAS and preeclampsia, and were enrolled
in the MoBa cohort from 2003 to 2007, as described in detail
elsewhere [20]. The eligibility criteria required singleton pregnan-
cies in women with no previous live or stillbirths and a mid-
pregnancy plasma sample. The present study included 470
preeclamptic patients and 483 non-preeclamptic women. The
latter group of women was randomly selected from all MoBa
women who met the eligibility criteria. To be included in the
present analysis, women had to have complete data on gestational
age at birth, birtweight, and maternal weight; 114 subjects were
excluded on that basis (74 of those for missing maternal weight),
leaving 953.
Ethics Statement
The study was approved by The Ethics Committee of the
Southern Healthcare Region of Norway (REK-SØR), the
Norwegian Data Inspectorate and the National Institute of
Environmental Health Sciences Institutional Review Board.
Participants provided their written informed consent to participate
in this study upon recruitment.
Lab analyses of plasma creatinine and GFR estimation
Maternal non-fasting blood samples were collected at enroll-
ment in the MoBa cohort (at the time of the second trimester
ultrasound scan). Samples were shipped to the biobank facilities in
Oslo from hospitals and maternity units throughout Norway and
the majority were received and processed the day after collection
[19]. Plasma was separated, aliquoted and stored in Oslo at 280
degrees Celcius until shipped to analyzing laboratories [19].
Samples were shipped on dry ice to the National Institute of
Environmental Health Sciences laboratory in Durham, USA and
plasma creatinine (modified Jaffé) was analyzed with an Olympus
AU400e Clinical Chemistry Analyzer (Olympus America, Inc.,
Irvin, TX, USA), using reagents from Beckman Coulter Inc.
(Irving, TX, USA). The between-assay coefficient of variation was
3%, based on 25 QA/QC specimens that were analyzed blindly (1
QA/QC specimen per batch). The mean level was 80.4 umol/l.
Plasma creatinine was used to estimate GFR based on the
formula of Cockroft-Gault (CG: GFR= (140–age)6weight
(kg)61,04/serum creatinine (mmol/l)), the modification of diet in
renal disease (MDRD: GFR=175 (serum creatinine [mmol/
l]60.011312)21.1546age20.20560.742) and the Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI: for females with
serum creatinine #62 mmol/L: GFR=144 (serum creatinine
[mmol/l]60.0113/0.7)20.3296(0.993)age in years, and for females
with serum creatinine .62 mmol/L: GFR=144 (serum creatinine
[mmol/l]60.0113/0.7)21.2096(0.993)age in years). The latter is a
recently developed equation to calculate eGFR.
Other variables
Infant birth weight, maternal age in years at delivery, and
gestational age in days was obtained from the Medical Birth
Registry of Norway (MBRN). The latter was estimated based on
ultrasound performed in week 18 at inclusion into the MoBa
cohort. Maternal weight in kilograms was based on self-report
from questionnaire 1, filled in prior to the ultrasound assessment.
Preeclampsia is reported to the MBRN as a dichotomized
variable. The sub-study cases were restricted to those whose
diagnosis was verified after review of antenatal medical records, as
described elsewhere [20].
Statistical analysis
Linear regression models in the total cohort were adjusted for
maternal weight (in kilograms), preeclampsia (yes/no) and
gestational age at delivery (days). Additional adjustment for
gestational length at blood draw and maternal diabetes had no
effect on the results. The birth weight-GFR relationship was
statistically homogeneous across preeclampsia status (p value for
interaction term .0.1), and underlying assumptions for linear
regression were fulfilled. Partial correlation coefficients were also
calculated with adjustment for the same covariates listed above.
We also performed stratified analyses on women with and without
preeclampsia, adjusting for maternal weight and gestational age at
delivery. The two-sided level of significance for all analyses was
0.05. All analyses were conducted using SPSS version 20.0.
Results
The characteristics of the 953 included women are outlined in
Table 1. The women were, on average, nearly 30 years old, and
delivered children with a birth weight about 200 g less than the
average in Norway (fhi.no), reflecting that half the pregnancies
were affected by preeclampsia. The mean value for GFR based on
the CG formula was higher (161.8 ml/min) than for the MDRD
formula (123.7 ml/min) or the CKD-EPI formula (121.6 ml/min).
Mean gestational age at blood draw was 129.8 days (18.5 weeks)
with a 95% confidence interval from 117 to 145 days. When
compared to the 483 women without preeclampsia, the 470
women with preeclampsia had significantly higher mean weight,
and significantly lower mean gestational age and birth weight; they
also had a significantly higher proportion of small-for-gestational-
age infants. Only GFR estimated by the CG formula was
significantly different between women with and without pre-
eclampsia.
Adjusted coefficients with standard errors (SE) from multiple
linear regression analysis of the association between infant birth
weight and maternal eGFR in second-trimester by the CG,
MDRD and the CKD-EPI formulas are outlined in table 2. The
difference in infant weight for each ml/min increase in eGFR was,
for the GC-formula, 0.73 g (SE 0.36 g, p,0.05); for the MDRD-
formula, 0.83 g (SE 0.41 g, p,0.05), and for the CKD-EPI-
formula, 0.04 g (SE 0.82 g, N.S.). The results based on the CKD-
EPI-formula were not further considered. Partial correlation
Maternal Glomerular Filtration and Fetal Size
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coefficients for the association between infant birth weight and
eGFR were 0.07 (p= 0.04) for both the CG- and MDRD formula.
In women with preeclampsia (n = 470) each ml/min increase in
GFR (in second trimester) the infant weight at delivery increased
by 1.1 gram (SE: 0.49 gram, p,0.05) when using the CG-formula
and with 1.3 gram (SE: 0.58 gram, p,0.05) when using the
MDRD-formula. The same analyses for women without pre-
eclampsia (n = 483) were not statistically significant (Table 2).
However, as noted above, the results were statistically homoge-
neous across groups with different preeclampsia status.
In Table 3 we have summarized the available data on the
relationship of birth weight with estimated maternal GFR. The
data are from two previous studies [10,12] and the present
analyses. All three studies indicate a relationship, with partial
correlation coefficients for the two previous studies of 0.44 [10]
and 0.03 [12], respectively. The b coefficients from the three
studies are statistically homogeneous, regardless of whether the
CG- or MDRD-based estimate from the present study is
considered. For the CG-based estimate, e.g., the x22 d.f. is 3.58
(p = 0.17).
Discussion
We found a significant association between estimated maternal
GFR in the second trimester and infant birth weight by using two
different formulas (CG and MDRD) for calculating eGFR in the
total cohort, but not when using a third recently developed
formula (CKD-EPI). The absolute values and difference in GFR
Table 1. Characteristics of 953 pregnant women in the Norwegian Mother and Child Cohort study, Norway, 2003–2007.
Women with preeclampsia Women without preeclampsia The total cohort
n =470 n=483 n=953
Mean (SD) Mean (SD) p-value Mean (SD)
Maternal age (years) 28.6 (4.5) 28.9 (4.5) 0.25 28.8 (4.5)
Maternal weight (kg) in mid-pregnancy
(at the time of estimated GFR)
73.9 (14.4) 69.4 (11.0) ,0.0001 71.6 (13.0)
Gestational age at blood draw (days) 129.6 (10.1) 129.9 (11.8) 0.67 129.8 (11.0)
Gestational age at delivery (days) 269.3 (20.7) 280.3 (11.8) ,0.0001 274.9 (17.6)
Creatinine (umol/l) 53.7 (13.7) 54.8 (14.0) 0.16* 54.2 (13.9)
GFR-CGa (ml/min) 169.4 (53.1) 154.4 (43.1) ,0.0001 161.8 (48.9)
GFR-MDRDb (ml/min) 125.8 (36.9) 121.7 (32.9) 0.07 123.7 (34.9)
GFR-CKD-EPIc (ml/min) 122.2 (16.9) 120.9 (16.6) 0.22 121.6 (16.8)
Infant birth weight (g) 3117 (780) 3521 (568) ,0.0001 3322 (710)
n (%) n (%) n (%)
Small-for-gestational-age
(,10th percentile)
116 (24.7) 55 (11.4) ,0.0001** 171 (17.9)
Means were compared with two samples T-test if not stated otherwise.
aGlomerular filtration rate estimated by Cockroft-Gault (CG) formula.
bGlomerular filtration rate estimated by modification of diet in renal disease (MDRD) formula.




Table 2. Adjusted coefficients with standard errors (SE) from multiple linear regression analysis of the association between infant
birth weight and maternal glomerular filtration rate (GFR) in second-trimester estimated by Cockroft-Gault (CG), modification of
diet in renal disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas, based on data from 470
women with preeclampsia, 483 women without preeclampsia and the total cohort of 953 pregnant women from the Norwegian
Mother and Child Cohort, Norway 2003–2007.
Women with preeclampsia Women without preeclampsia The total cohort
Adjusted ba Adjusted ba Adjusted bb
(SE) (SE) (SE)
GFR by CG formula 1.1* (0.49) 0.24 (0.52) 0.73* (0.36)
GFR by MDRD formula 1.3* (0.58) 0.23 (0.58) 0.83* (0.41)
GFR by CKD-EPI formula 3.0* (1.3) 1.3 (1.1) 0.04 (0.82)
*significance at the 0.05 level.
aadjusted for maternal weight (kg) and gestational age in days. The unit for b with SE in gram.
badjusted for maternal weight (kg), preeclampsia and gestational age in days. The unit for b with SE in gram.
doi:10.1371/journal.pone.0101897.t002
Maternal Glomerular Filtration and Fetal Size
PLOS ONE | www.plosone.org 3 July 2014 | Volume 9 | Issue 7 | e101897
between formulas were in accordance with previous studies in
pregnant women [14]. When summarizing all available data on
the issue, including two previous studies [10,12] all three studies
indicate a relationship, with partial correlation coefficients of 0.07,
0.44 and 0.03, for the current and the two previous studies,
respectively. When stratifying on preeclampsia, we found statisti-
cally significant results only for women with preeclampsia, which
confirmed that including women with preeclampsia in the total
cohort increased the study power, because it increased the
proportion of small-for-gestational-age (SGA) newborns in the
analysis [21].
Although the estimates of the relationship between birth weight
and GFR from the present two earlier studies [10,12] appeared
different, they were not only qualitatively in agreement, but they
were also statistically homogeneous. Nonetheless, the coefficients
for the birth weight-GFR relation in the two previous studies by
Gibson [10] and Dunlop [12] seemed quite different from one
another despite that inulin clearance (the gold standard method of
estimating GFR) was used. Both studies were performed on limited
number of patient (20 and 25, respectively). The study by Gibson
[10], however, had three SGA infants and this may account for
why that study had sufficient power to detect a birth weight-GFR
relationship. The subjects in the Dunlop study [12] had a narrow
range of birth weights, and none of the infants were SGA, and that
may explain why the standard error is relatively large in that
analysis. Even though eGFR is not as precise or accurate as inulin
clearance, the much larger sample size and inclusion of many
more SGA newborns in the present study not only strengthened
the evidence that an association exists, but resulted in a direct,
quantitative estimate of the size of the association, which will be of
use in epidemiologic and pharmacokinetic studies. To our
knowledge this is the first study to estimate the relationship
between fetal size and GFR in direct, quantitative terms. While the
relationship between birth weight and GFR is statistically
significant, the magnitude of the relationship, as reflected
intuitively by the partial correlation coefficient of 0.07, is quite
modest. Nonetheless, this modest relationship may result in
significant confounding in studies of birth weight in relation to
PFAS concentrations.
To illustrate the importance of the birth weight-GFR relation-
ship to epidemiologic results on birth weight and PFAS
concentrations in pregnancy, we analyzed the data for the 953
subjects in a model of birth weight in relation to the concentration
of perfluoroctanoic acid (PFOA), adjusted for pre-pregnancy body
mass index (kg/m2), gestational age at birth, gestational weight
gain, and preeclampsia. (Except for the adjustment for preeclamp-
sia, this is the model of birth weight and PFOA in Whitworth et al.
[6], fitted to data for another group of MoBa subjects. Plasma
creatinine was not measured in the Whitworth et al. study;
however PFAS were measured among the subjects in the present
study.) Further adjustment for GFR-CG caused the PFOA
coefficient to attenuate by 66% (not shown).
The estimated association between GFR and infant birth weight
will tend to be influenced by random errors in measurement of
plasma creatinine and more accurate assessments of the relation-
ship would need to be based on GFR gold standard measurements
rather than eGFR. Others have found an intraclass correlation
coefficient of 0.76 for serum creatinine in women who had their
levels measured 2 to 3 years apart [22]. Under the assumption that
this translates directly into an intraclass correlation coefficient for
GFR, the b after correction for this error will be 30% larger (b-
CG: 0.73/0.76= 0.96 and b-MDRD: 0.83/0.76= 1.09) than what
we observed for both the indirect formulas (Willett WC,
Nutritional Epidemiology. New York: Oxford University Press.
1990, page 200). This measurement error-corrected estimate of b
might be useful in pharmacokinetic models.
Pregnancy induces marked changes in renal function charac-
terized by hyperfiltration, accompanied by systemic vasodilatation
and plasma volume expansion that is fully established in mid-
pregnancy [23,24]. The GFR may increase as much as 60%
compared to the pre-pregnant value [14]. Several methods are
available to measure GFR, however, no consensus exists on what
method is the most suitable in pregnancy [14]. The gold standard
method of estimating GFR is inulin clearance, a costly and time
consuming examination, unsuitable for large scale settings, like our
study and in clinical settings. The most widely clinically used
methods are based on single-point measurements of serum
creatinine with formulas for calculation of GFR (CG and MDRD).
Both the direct method (inulin clearance) and the indirect methods
(CG and MDRD) underestimate GFR in pregnancy [14].
However, differences between inulin-based GFR and GFR
obtained from single-point measurements of serum creatinine
(CG and MDRD) stayed the same with increasing GFR [14]. It is
therefore unlikely that the bias in the CG and MDRD GFR
estimates will have substantially affected our estimation of the
association between GFR and birth weight. The CKD-EPI
formula showed no significant association with birth weight in
the total cohort, but only when the women with preeclampsia were
analyzed alone. This formula is an even poorer predictor of GFR
Table 3. Relationship between glomerular filtration rate (GFR in pregnancy and birth weight, estimated in three studies.




(ml/min) b g bw/GFRratio
a SE (b) Partial rb
Gibson2, 1973c 20 28 152 1603d 784e 0.44
Dunlop4, 1981c 25 26 152 67d 535f 0.03
Present study, MDRD 953 18 124 103 51 0.07
Present study, CG 953 18 162 118g 57 0.07
aGFRratio is the ratio of subject i’s GFR to the mean GFR. We used this metric to compare results across studies to adjust for differences in gestational week when GFR
was measured.
bPartial r is partial correlation coefficient.
cmeasured GFR using inulin clearance.
dThe beta and partial r for Gibson and Dunlop studies were calculated conditional on gestational age at birth, using the raw data in the original publications.
eGibson had three SGA infants; their inclusion probably accounts for why that study had sufficient power to detect a birth weight-GFR relationship.
fThe subjects in the Dunlop study had a narrow range of birth weights, and that may explain why the standard error is relatively large in that analysis.
gTaking the intraclass correlation coefficient (ICC) for creatinine into account gives a corrected b (SE) for the CG formula of 155 (75) (see text).
doi:10.1371/journal.pone.0101897.t003
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in some groups [25], especially pregnant woman [26], which may
explain the divergence in results.
The major strength of our data was the large sample of women
who had their GFR estimated compared to the previous studies
[9,10], and the relatively large proportion of newborns who were
SGA. Despite the strengths, our data have some limitations. Data
on maternal weight were obtained from questionnaires and were
self-reported. In general, self-reported weight is fairly accurate and
precise, and that might be even more true during pregnancy [27–
29]. Shipment of blood samples for a day at ambient temperature
may have affected creatinine values in this study. The delayed
separation of whole blood and ambient temperature may have
increased levels of plasma creatinine [30]. Thus, our estimates of
GFR may have been too low and more imprecise than usual;
however, the effect on our estimate of the birth weight-GFR
relationship would be to bias it towards the null. The most
important weakness of the present study, however, was that the
estimate of GFR used was imprecise compared with direct
measures of GFR, based on clearance. All the formulas for
calculation of GFR based on serum creatinine (CG, MDRD and
EPI-CKD) are based on large cohorts of non-pregnant patients
with at least mild renal insufficiency [26] and appear to be
insufficient for estimating GFR in pregnant women [15,31] and
healthy individuals [32]. Particularly, the MDRD formula
systematically underestimates GFR at higher values (above 60
ml/min/1.73 m2) [16]. A formal calculation of the effect of the
imprecision on our b is beyond the scope of the present study, but
suppose, for the sake of argument, that the true b was
underestimated by about 100%. Assuming that the true b is
2 g/ml/min and the standard deviations of birth weight and GFR-
CG are as given in table 1 (women without preeclampsia), with
0.80 power and a two-sided alpha of 0.05, 343 patients would need
to be studied with a gold standard method (http:/Hedwig.mgh.
harvard.edu/sample_size/js/js_associative_quant.html). This
number could be decreased by enriching the sample with SGA
infants [21], which could perhaps be done using mid-pregnancy
ultrasound.
Conclusion
These data support a modest, positive association between GFR
during pregnancy and infant birth weight, and indicate that GFR
may confound selected epidemiologic associations. The quantita-
tive estimate of the relationship presented, although provisional
until better estimates become available, will also inform pharma-
cokinetic studies of the extent of such confounding.
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